Identification of Novel Drug Targets for the Treatment of Diabetic Retinopathy
Vision loss in diabetic retinopathy (DR) is attributable to retinal vascular disorders that result in macular edema and neoangiogenesis. In addition to laser photocoagulation therapy, intraocular injections of antivascular endothelial growth factor drugs have contributed to the treatment of these di...
| Hlavní autor: | |
|---|---|
| Médium: | Článek |
| Jazyk: | English |
| Vydáno: |
Korean Diabetes Association
2013-08-01
|
| Edice: | Diabetes & Metabolism Journal |
| Témata: | |
| On-line přístup: | http://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-37-217.pdf |